Image

Pranshu Bansal, MD

Medical Oncologist

Head & Neck

Lung

"Dr Bansal helped my mother with her treatments for cancer. He and his staff have been great. After what was initially a fatal diagnosis in the ER, Dr Bansal has given us some hope and was very upfront about all the possibilities, both good or bad. Everyone who works there has been friendly, helpful and cheerful as possible, given the circumstances."

Dr. Bansal is a triple board-certified oncologist. He specializes in lung, head & neck malignancies as well as hematologic disorders. He has a diverse breadth of experience both in training and in practice. He has trained at nationally renowned institutions in the US and India. He has published multiple research articles in the field of oncology and lung cancer, he has presented his research at national meetings over the years. He is at present an investigator in research trials.

He takes a lot of pride in offering the best treatment tailored to every individual patient which involves use of targeted therapies, immunotherapies and supportive care services. The rapidly evolving field of cancer treatments is very promising for both patients and physicians and it’s his endeavor to help every patient find their best fit to navigate through a difficult time in their lives.

Present Title & Subspecialties

Title

Medical Oncology & Hematology

Subspecialties

Head & NeckLung

Education & Training

Medical School

Vardhman Mahavir Medical College and Safdarjung Hospital  New Delhi- India

Fellowships

The University of New Mexico, Albuquerque, NM ,Hematology & Medical Oncology
Cancers Treated
Certifications & Professional Memberships

  • Board Certified in Hematology & Medical Oncology
  • Indian Red Cross
  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • HLH society of America

Publications

Articles in peer-reviewed journals

Loo E, Bansal P, Cherukuri D, Arana Yi C Isodicentric Philadelphia chromosome: an uncommon chromosomal abnormality in the chronic phase of chronic myeloid leukemia (CML). Clinical case Reports. Nov 19 2015 PMID 2678434

Bansal P, Osman D, Gan G, Simon GR, Boumber Y. Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC. Frontiers in Oncology 6 (2016). PMID 27200298.

Bansal P, Rusthoven C, Boumber Y, Gan GN. The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. Future oncology (London, England) . PMID 27467543

Bansal P, Osman D, Simon G, Gan GN, Boumber Y Recent advances in immunotherapy in NSCLC. Frontiers in oncology May 2016 PMID 27200298.

Hu S, Bansal P, Lynch D, Hernandez CMR, Dayao Z. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature. Journal of Medical Case Reports. Dec 20 2016  PMID 27998299

Castresana D, Bansal P, Vasef MA, Kapoor V, Leone C, Quintana D. Aggressive lymphoma presenting as dysphagia: A rare cause of dysphagia. Clinical case repots. March 13 2017. PMID 28469848

Marchio S, Bansal P, Pasqualini R, Arap W. An antivascular vaccine to boost self-immunity and strike the tumor. Proceedings of National Academy of Science. Apr 18 2017 PMID 28400521

Patt YZ, Murad W, Fekrazad M,  Baron A, Bansal P, Boumber Y , Steinberg K, LEE S-J,  Bedrick E, Du R,  Lee FC. INST OX-05-024: First Line Gemcitabine, Oxaliplatin and Erlotinib for Primary Hepatocellular Carcinoma (HCC) and Bile Duct Cancers (BDC): A multicenter Phase II Trial. Cancer Medicine.  Aug 11 2017. PMID 28801995

PATT YZ, Hernandez RC, Fekrazad H, Bansal P, Lee FC. Phase II trial of sorafenib in combination with capecitabine in patients with hepatocellular carcinoma: INST 08-20. The Oncologist June 1 2017. PMID 28687627

Araujo Mino EP, Patt YZ, Murray-Crezan C, Hanson JA, Bansal P, Liem BJ, Rajput A, Fekrazad MH, Heywood G, Lee FC. Phase II trial using a combination of Capecitabine, Oxaliplatin and Celcoxib with concurrent Radiation for newly diagnosed Resectable Rectal cancer. The Oncologist November 20 2017. PMID 29153865

Hilal T, Bansal P, Kelemen K, Slack J. Nivolumab associated bone marrow necrosis. Annals of oncology February 1 2018. PMID 29351576

Arora S, Velichinskii R, Lesh WR, Ali U, Kubaik M, Bansal P,  Borghaei H, Edelman MJ, Boumber Y- Existing and emerging role for checkpoint Immunotherapy in solid tumors- Advances in therapy October 2019 Volume 36, Issue 10 pp 2638-2678. PMID 31410780

Qeadan F; Bansal P; Hanson JA; Beswick E “The MK2 pathway is linked to G-CSF, cytokine production and metastasis in gastric cancer: a novel intercorrelation analysis approach” Journal of translational medicine volume 18, Article number: 137 (2020) PMID 32216812

Shaheen MF,Julie TY, Sokol SE, Masterson M, Bansal P , Ian Rabinowitz, Arap W et al “Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial” Journal E Life Sciences June 7 2022 PMID 35787844

Book Chapters

Williamson EA, Wray JW, Bansal P, Hromas R. Overview for the histone codes for DNA repair. Prog Mol Biol Transl Sci. 2012;110:207-27.

 

Honors & Awards

2007- Distinction in Professional I- Physiology

2004- State Winner National Science Olympiad in Chemistry, India

CV
Videos

Videos

Languages

Location

Mesa (Arbor)

6111 E. Arbor Ave

Mesa, AZ 85206

Hours:

Monday- Friday

8am-5pm

Contact
480-981-1326
480-981-1445
Reviews for Pranshu Bansal, MD
  • Image
  • Image
  • Bhangoo + Bansal Testimonial
  • Image
  • Image
  • Image
  • Image
  • Image
  • Bansal Testimonial
  • Bansal Testimonial
  • Bansal Testimonial
    pixel